Published in Clin Exp Immunol on September 01, 2002
Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum (2008) 3.35
Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther (2005) 3.17
IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol (2005) 1.10
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res Ther (2005) 1.07
Current status and challenges of cytokine pharmacology. Br J Pharmacol (2009) 0.91
Differential regulation of osteoblast activity by Th cell subsets mediated by parathyroid hormone and IFN-gamma. J Immunol (2005) 0.89
All-trans-retinoic acid suppresses interferon-gamma and tumor necrosis factor-alpha; a possible therapeutic agent for rheumatoid arthritis. Rheumatol Int (2005) 0.87
Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis. Arthritis Res Ther (2006) 0.85
Predicting the survival time for diffuse large B-cell lymphoma using microarray data. J Mol Genet Med (2012) 0.82
Role of basophils in rheumatoid arthritis (Review). Exp Ther Med (2015) 0.78
Commercial bovine proteoglycan is highly arthritogenic and can be used as an alternative antigen source for PGIA model. Biomed Res Int (2014) 0.76
Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker. Arthritis Res Ther (2017) 0.75
Gαq Regulates the Development of Rheumatoid Arthritis by Modulating Th1 Differentiation. Mediators Inflamm (2017) 0.75
Ethyl Caffeate Ameliorates Collagen-Induced Arthritis by Suppressing Th1 Immune Response. J Immunol Res (2017) 0.75
Boi-ogi-to (TJ-20), a Kampo Formula, Suppresses the Inflammatory Bone Destruction and the Expression of Cytokines in the Synovia of Ankle Joints of Adjuvant Arthritic Rats. Evid Based Complement Alternat Med (2017) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 16.28
Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med (2001) 7.41
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet (1997) 6.71
Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet (1981) 6.62
Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med (2000) 6.57
CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med (2000) 6.06
Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol (1992) 4.92
The Th1/Th2 paradigm. Immunol Today (1997) 3.96
Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum (1997) 3.80
How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum (1990) 3.78
Th1/Th2 cytokine balance in arthritis. Arthritis Rheum (1997) 3.11
Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet (1994) 2.96
Interleukin-10. Curr Opin Immunol (1992) 2.85
The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum (1992) 2.68
Biological properties of interleukin 10. J Clin Immunol (1992) 2.50
A gamma-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity. Nature (1987) 2.48
Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum (1997) 2.21
The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol (2000) 2.17
The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum (1997) 2.07
Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum (1996) 2.03
Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum (1973) 2.03
Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest (1995) 1.76
T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol (1992) 1.58
Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum (1995) 1.42
Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis. Ann Rheum Dis (1985) 1.30
High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum (1995) 1.26
The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium. Arthritis Rheum (1992) 1.25
Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum (1996) 1.22
Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol (1993) 1.20
Efficient propagation and cloning of human T cells in the absence of antigen by means of OKT3, interleukin 2, and antigen-presenting cells. Scand J Immunol (1988) 1.19
Cytokine, activation marker, and chemokine receptor expression by individual CD4(+) memory T cells in rheumatoid arthritis synovium. Arthritis Res (2000) 1.18
CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms. Blood (2002) 1.16
Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4. Ann Rheum Dis (2000) 1.16
Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur J Immunol (1997) 1.15
Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol (2000) 1.14
Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum (2000) 1.12
Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum (1999) 1.10
Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Ann Rheum Dis (1997) 1.07
Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum (2001) 1.06
Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium. Scand J Immunol (1999) 1.06
T cell immunoregulation in rheumatoid synovitis. Arthritis Rheum (1988) 1.05
CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role. J Immunol (2000) 0.99
Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. J Clin Invest (1997) 0.98
Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases. Trends Immunol (2001) 0.97
The pathophysiology and treatment of rheumatoid arthritis. Arthritis Rheum (1997) 0.94
Are T cells in rheumatoid synovium aggressors or bystanders? Curr Opin Rheumatol (2000) 0.92
Are differences in interleukin 10 production associated with joint damage? Rheumatology (Oxford) (2000) 0.92
Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. Rheumatology (Oxford) (1999) 0.91
The method of deriving human T-cell clones alters the proportion of IL-10-producing cells. Immunology (1996) 0.91
Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype. Clin Exp Immunol (1997) 0.90
Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen. J Clin Invest (1990) 0.88
CD8+CD11b+ peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors. Eur J Immunol (1989) 0.87
Skewed T-cell receptor variable gene usage in the synovium of early and chronic rheumatoid arthritis patients and persistence of clonally expanded T cells in a chronic patient. Rheumatology (Oxford) (2000) 0.87
Diversity of rheumatoid synovial tissue T cells by T cell receptor analysis. Oligoclonal expansion in interleukin-2-responsive cells. Arthritis Rheum (1991) 0.87
Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy. Rheumatology (Oxford) (1999) 0.86
T-cell trafficking into sites of inflammation. Rheumatology (Oxford) (2000) 0.80
Is one year early, or too late? Comment on the article by Tak et al. Arthritis Rheum (1997) 0.77
PCR-based analysis of the TCR repertoire in human autoimmune diseases. Immunol Today (1992) 1.69
Increased allergen-specific, steroid-sensitive gamma delta T cells in bronchoalveolar lavage fluid from patients with asthma. Ann Intern Med (1996) 1.61
Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age. Blood (1991) 1.52
Expression of B7 co-stimulatory molecules and CD1a antigen by alveolar macrophages in allergic bronchial asthma. Clin Exp Allergy (1998) 1.47
Selective endoscopic retrograde cholangiography and preoperative bile duct stone removal in patients scheduled for laparoscopic cholecystectomy: a prospective study. Am J Gastroenterol (1996) 1.45
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. Infect Immun (2000) 1.39
Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut (1994) 1.27
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology (1999) 1.22
gamma delta T cells, allergen recognition and airway inflammation. Immunol Today (1998) 1.22
Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev (2000) 1.17
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol (2000) 1.14
Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci U S A (1992) 1.13
Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol (1999) 1.11
Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology (1995) 1.10
Gynecomastia during omeprazole therapy. N Engl J Med (1991) 1.07
DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis. Eur J Immunol (2001) 1.05
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. Br J Pharmacol (2000) 1.04
Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology (1996) 1.03
Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology (2000) 1.00
CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role. J Immunol (2000) 0.99
T lymphocytes bearing the gamma delta T cell receptor are susceptible to steroid-induced programmed cell death. Scand J Immunol (1995) 0.99
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol (1995) 0.97
Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases. Trends Immunol (2001) 0.97
Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients. Clin Exp Immunol (1994) 0.96
Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F. Hum Mol Genet (1993) 0.93
First results from the XENON10 dark matter experiment at the Gran Sasso National Laboratory. Phys Rev Lett (2008) 0.93
Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens. Dig Dis Sci (1995) 0.92
Serum level of soluble intercellular adhesion molecule 1 in patients with chronic liver disease related to hepatitis C virus: A prognostic marker for responses to interferon treatment. J Infect Dis (2000) 0.92
Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha? Atherosclerosis (1999) 0.91
Gene expression profiling in dermatitis herpetiformis skin lesions. Clin Dev Immunol (2012) 0.90
High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints. Clin Exp Immunol (1995) 0.90
Depression and anxiety in perinatal period: prevalence and risk factors in an Italian sample. Arch Womens Ment Health (2011) 0.89
CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis. Clin Immunol Immunopathol (1996) 0.89
Local expansion of allergen-specific CD30+Th2-type gamma delta T cells in bronchial asthma. Mol Med (1995) 0.89
In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy (2005) 0.89
Long term treatment of rheumatoid arthritis with high doses of intravenous immunoglobulins: effects on disease activity and serum cytokines. Ann Rheum Dis (1995) 0.89
Defective expression of Fas messenger RNA and Fas receptor on pulmonary T cells from patients with asthma. Ann Intern Med (1998) 0.88
Schnitzler's syndrome treated successfully with intravenous pulse cyclophosphamide. Scand J Rheumatol (2005) 0.88
Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology (Oxford) (2004) 0.87
Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon. Clin Sci (Lond) (1999) 0.86
Polarization of the alpha 6 beta 4 integrin in ovarian carcinomas. Int J Cancer (1993) 0.86
Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy. Rheumatology (Oxford) (1999) 0.86
Search for light dark matter in XENON10 data. Phys Rev Lett (2011) 0.86
Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis. Scand J Rheumatol (2006) 0.86
Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol (1998) 0.85
Biological effects of montelukast, a cysteinyl-leukotriene receptor-antagonist, on T lymphocytes. Clin Exp Allergy (2004) 0.85
Functional characterization of T cells bearing the gamma/delta T-cell receptor in patients with primary Sjögren's syndrome. Clin Exp Rheumatol (1993) 0.85
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis. Lab Invest (2000) 0.84
Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. Aliment Pharmacol Ther (2002) 0.84
A 1.1-kb duplication in the p67-phox gene causes chronic granulomatous disease. Hum Genet (2001) 0.83
Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndrome. Lupus (2011) 0.83
Rare presentation of endometrial carcinoma with singular bone metastasis. Eur J Cancer Care (Engl) (2009) 0.83
Type III procollagen peptide and PZ-peptidase serum levels in pre-cirrhotic liver diseases. Clin Chim Acta (1985) 0.83
Oesophageal lesions during treatment with piroxicam. BMJ (1990) 0.83
Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis. Rheumatology (Oxford) (2002) 0.82
Identification of three novel mutations in the PIG-A gene in paroxysmal nocturnal haemoglobinuria (PNH) patients. Hum Genet (1996) 0.82
Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons. Eur J Pharmacol (2000) 0.82
Is the Melkersson-Rosenthal syndrome related to the exposure to food additives? A case report. Oral Surg Oral Med Oral Pathol (1989) 0.82
Salicylates inhibit adhesion and transmigration of T lymphocytes by preventing integrin activation induced by contact with endothelial cells. Blood (1998) 0.82
Unicentric Castleman's lymphadenopathy presenting with Behçet's syndrome: a case report. Haematologica (1991) 0.81
IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome. Reumatismo (2013) 0.81
Food allergy and rheumatoid arthritis. Clin Exp Rheumatol (1989) 0.81
Costimulation of CD3/TcR complex with either integrin or nonintegrin ligands protects CD4+ allergen-specific T-cell clones from programmed cell death. Allergy (1995) 0.81
Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity. Reumatismo (2012) 0.80
BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups. Ann Oncol (2013) 0.80
Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells. Haematologica (1998) 0.80
CD4+IL13+ T lymphocytes at birth and the development of wheezing and/or asthma during the 1st year of life. Int Arch Allergy Immunol (2001) 0.80
GABA (gamma-amino-butyric acid) neurotransmission: identification and fine mapping of the human GABAB receptor gene. Biochem Biophys Res Commun (1998) 0.80
Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy. Clin Rheumatol (1994) 0.80
Abscess formation in hepatocellular carcinoma: complications of percutaneous ultrasound-guided ethanol injection. J Clin Ultrasound (1993) 0.79
Targeted approaches to triple-negative breast cancer: current practice and future directions. Curr Med Chem (2013) 0.79
CD4 T cells in the rheumatoid joint are oligoclonally activated and change during the course of disease. Ann Rheum Dis (1995) 0.79
Salicylates inhibit T cell adhesion on endothelium under nonstatic conditions: induction of L-selectin shedding by a tyrosine kinase-dependent mechanism. J Immunol (2001) 0.79
The plasticity of dendritic cells at the host/fungal interface. Immunobiology (2001) 0.78
FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. Nutr Metab Cardiovasc Dis (2011) 0.78
Juvenile psoriatic arthritis and acquired sensorineural hearing loss in a teenager: is there an association? Clin Exp Rheumatol (2006) 0.78
Co-stimulation-induced release of pro-inflammatory cytokine interleukin-8 by allergen-specific T cells. Scand J Immunol (1996) 0.78
Analysis of the T cell receptor repertoire in rheumatoid arthritis. Clin Exp Rheumatol (1997) 0.78
Hereditary hemochromatosis: generation of a transcription map within a refined and extended map of the HLA class I region. Genomics (1996) 0.78
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. Aliment Pharmacol Ther (1998) 0.78
Food allergy and seronegative arthritis: report of two cases. Clin Rheumatol (2001) 0.78
Intracellular calcium levels are differentially regulated in T lymphocytes triggered by anti-CD2 and anti-CD3 monoclonal antibodies. Cell Signal (1995) 0.77
Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases. Clin Rheumatol (2004) 0.77
Overall survival in BRCA-associated ovarian cancer: case-control study of an Italian series. Eur J Gynaecol Oncol (2010) 0.77
[Topical cyclosporine in the treatment of oral pemphigus]. Minerva Stomatol (1998) 0.77
Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA). Clin Exp Rheumatol (2007) 0.77
The biology of cypress allergy. Allergy (2002) 0.77
Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability. Hum Immunol (2000) 0.76